Catalyst Wire Dossier Catalyst Wire Dossier

Desloratadine with oxybutynin

· Organon and Co
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Desloratadine with oxybutynin, covering 2022-02-16 to 2022-02-16. Get the full timeline:

Most recent: Clinical Trial Update: Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED) [Phase 2]

See pricing